End-of-day scoring · Prices as of last close
Educational Analytics — No Financial Advice
Scanning 9,000+ Stocks & Crypto
_
Silence Therapeutics Plc
Silence Therapeutics creates RNA-based therapies that turn off genes linked to diseases, helping patients with conditions like cancer or genetic disorders. Doctors and hospitals use these treatments when standard drugs fail, aiming for more targeted and effective care. The company makes money by licensing its technology to big drug makers and receiving payments from research collaborations.
This company operates in the biotechnology sector, focusing on developing treatments that target specific genes. It uses RNA interference technology to silence genes that cause diseases, offering a novel approach compared to traditional drugs. The biotech industry is highly competitive and research-intensive, with success depending on clinical trial results and regulatory approvals.
Intelligence Pipeline Active
ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.
No active score modifiers detected
Price is overextended from the 20-day trend lead.
Price is extended significantly above 52-week highs.
Banana Farmer tracks 100's of signals to synthesize this proprietary score.
Our engine is currently indexing SLN across global social channels to detect early sentiment shifts and technical alignment.
Intelligence Narrative Connected
Educational only.
Loading chart...
Loading chart...
Loading chart...
Loading chart...